Faculty & Staff
Clinical Staff Bios
Anu Asnaani, Ph.D.
Description of research
Anu Asnaani, Ph.D., is an Assistant Professor of Clinical Psychology in Psychiatry at the Center for the Treatment and Study of Anxiety. Dr. Asnaani received her Bachelor of Science degree in psychology from Brown University and her Doctoral degree in clinical psychology from Boston University. During her doctoral study, Dr. Asnaani conducted research on emotion regulation processes, treatment outcome in social anxiety, and cross-cultural aspects of the diagnosis and treatment of anxiety disorders. Dr. Asnaani completed her clinical internship at the Warren Alpert Medical School of Brown University, where she examined the longitudinal course of PTSD and its impacts on health outcomes in recently returning OEF/OIF veterans. Her current interests include understanding how diversity influences emotion regulation, improving treatment outcome, and effectively increasing dissemination of empirically supported treatments for PTSD and other anxiety disorders. Dr. Asnaani specializes in cognitive-behavioral treatment for social anxiety, panic disorder, specific phobias, generalized anxiety, substance use disorders, and in Exposure and Response Prevention (EX/RP) for OCD.
Asnaani, A., Sawyer, A.T., Aderka, I.M., & Hofmann, S.G. (2013). Effect of suppression, reappraisal, and acceptance of emotional pictures on acoustic eye-blink startle magnitude. Journal of Experimental Psychopathology.
Hofmann, S.G., Asnaani, A., Vonk, I.J.J., Sawyer, A.T., & Fang, A. (2012). A review of meta-analyses of cognitive behavioral therapies. Cognitive Therapy and Research, 36, 427-440.
Hofmann, S.G., Sawyer, A.T., Fang, A., & Asnaani, A. (2012). An emotion dysregulation model of anxiety and mood disorders. Depression and Anxiety, 29, 409-416.
Asnaani, A., & Hofmann, S.G. (2012). Collaboration in culturally responsive therapy: Establishing a strong therapeutic alliance across cultural lines. Journal of Clinical Psychology: In Session, 68, 187-197.
Fang, A., Sawyer, A.T., Asnaani, A., & Hofmann, S.G. (2012). Social cost exposures for social anxiety disorder. Cognitive and Behavioral Practice, doi:10.1016/j.cbpra.2012.05.003
Chou, T., Asnaani, A., & Hofmann, S.G. (2012). Perception of racial discrimination and psychopathology across three U.S. ethnic minority groups. Cultural Diversity and Ethnic Minority Psychology, 18, 74-81.
McLean, C., Asnaani, A., Litz, B., & Hofmann, S.G. (2011). DSM-IV anxiety disorders across gender: Results from the Collaborative Psychiatric Epidemiology Studies. Journal of Psychiatric Research, 45, 1027-1035.
Hofmann, S.G., Smits, J.A.J., Asnaani, A., Gutner, C.A., & Otto, M.W. (2011) Cognitive enhancers for anxiety disorders. Pharmacology, Biochemistry, & Behavior, 99, 275-284.
Hofmann, S.G., Asnaani, A., & Hinton, D.E. (2010). Cultural aspects in social anxiety and social anxiety disorder. Depression and Anxiety, 27, 1117-1127.
Asnaani, A., Richey, J.A., Dimaite, R., Hinton, D.E., & Hofmann, S.G. (2010). A cross-ethnic comparison of lifetime prevalence rates of anxiety disorders. Journal of Nervous and Mental Disease, 198, 551-555.
Hofmann, S.G., Richey, J.A., Asnaani, A., & Sawyer, A.T. (2010). Avoiding treatment failures in Social Anxiety Disorder. In Otto, M.W., & Hofmann, S.G. (eds.), Avoiding Treatment Failures in the Anxiety Disorders. New York, NY: Springer Publishing.
Lewis-Fernandez, R., Hinton, D.E., Laria, A.J., Patterson, L.H., Hofmann, S.G., Craske, M.G.,Stein, D.J., Asnaani, A., & Liao, B. (2010). Culture and the anxiety disorders: Recommendations for DSM-V. Depression and Anxiety, 27, 212-229.
Hofmann, S. G., Glombiewski, J., Asnaani, A., & Sawyer, A.T. (2010). Mindfulness and acceptance: The perspective of cognitive therapy. In Herbert, J., & Forma, E. (eds.), Acceptance and Mindfulness in Cognitive Behavior Therapy. New York, NY: Springer Publishing.
Asnaani, A., Gutner, C.A., Hinton, D.E., & Hofmann, S.G. (2009). Panic Disorder, panic attacks and panic attack symptoms across race-ethnic groups: Results of the Collaborative Psychiatric Epidemiology Studies. CNS Neuroscience & Therapeutics, 15(3), 249-254.